Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Nov 13, 2026
TickeronGET DAILY SIGNALS
Odysight.ai (ODYS) Stock Falls 14.9% in a Month, Down 55% for the Quarter

Odysight.ai (ODYS) Stock Falls 14.9% in a Month, Down 55% for the Quarter

Key Takeaways

  • Odysight.ai (ODYS) shares declined roughly 14.9% over the last 30 days, falling from about $2.15 to approximately $1.83.
  • The move extends a broader downtrend, with the stock down roughly 55% over the trailing quarter from around $4.07.
  • Persistent net losses, declining annual revenue, and heavy customer concentration remain key fundamental concerns for investors.
  • As a micro-cap with thin daily trading volume, ODYS is prone to outsized price swings on relatively small order flow.
  • The company's fiscal 2025 results showed revenue down about 24% year over year alongside a widening net loss.
  • For additional detail, review Odysight.ai's Price Targets, Earnings, and Forecast pages.
  • Explore Trending AI Robots to see AI-driven trading strategies across the market.

Company Background and Market Position

Odysight.ai Inc., formerly known as ScoutCam Inc., is a Nevada-incorporated company headquartered in Ramat Gan, Israel, with additional subsidiaries in Europe. The company develops AI-powered visual sensing solutions for predictive maintenance (PdM) and condition-based monitoring (CBM), deploying compact, rugged video sensors in hard-to-reach locations and harsh environments across aerospace, defense, transportation, energy, and industrial (Industry 4.0) applications.

Odysight.ai's platform combines visual sensors, edge processing units, and cloud-based analytics to give maintenance and operations teams real-time visibility into equipment that is otherwise inaccessible during normal operation. Its technology has been adopted by organizations including the Israeli Air Force, the Israeli Ministry of Defense, NASA, Israel Railways, and Elbit Systems, underscoring its credibility in defense and industrial aviation. The company uplisted to the Nasdaq Capital Market in February 2025, raising approximately $23.7 million in gross proceeds at $6.50 per share. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Stock Price Performance Over the Last 30 Days and Quarter

Over the last 30 days, ODYS declined approximately 14.9%, moving from a closing level near $2.15 to an available price around $1.83. The decline was not a single-day event but rather a steady grind lower punctuated by several sharper down sessions, reflecting sustained selling pressure rather than a one-off shock.

The quarterly picture is more pronounced. Three months earlier, the stock traded near $4.07, meaning ODYS has shed roughly 55% of its value over the trailing quarter. The prolonged slide indicates that the stock has remained under persistent distribution pressure, with brief bounces failing to hold as sellers continued to dominate.

Factors Behind the Recent 30-Day Move

The recent 30-day decline reflects a combination of micro-cap dynamics and underlying fundamental headwinds rather than any single publicly disclosed catalyst. ODYS trades with notably thin volume on many sessions, and several of its sharpest down days occurred on elevated but still modest turnover, a pattern typical of low-float stocks where relatively small sell orders can move prices significantly.

Broader fundamental concerns continue to weigh on sentiment. In its fiscal 2025 annual report, the company disclosed revenue of approximately $3.0 million, down about 24% from the prior year, alongside a net loss that widened to roughly $17 million. The revenue decline was driven in part by the derecognition of a contract liability tied to a Fortune 500 medical customer. The company also noted that three customers accounted for approximately 98% of total revenue, a concentration that heightens risk if any key relationship weakens. From what I see, this customer concentration stands out as a notable risk factor worth monitoring closely.

Drivers of the Quarter-Long Decline

The quarter-long downtrend reflects a broader reassessment of Odysight.ai's valuation since its Nasdaq uplisting. After initially trading at higher levels following its early-2025 public offering, the stock has steadily drifted lower as investors weighed the company's limited revenue base, expanding operating expenses, and path to profitability.

Operating expenses rose sharply in fiscal 2025, driven by research and development, global sales expansion, and one-time costs related to the uplisting, while revenue did not keep pace. Management has acknowledged that the company expects expenses to continue growing and that additional capital may be required before profitability is reached, introducing ongoing dilution risk. Geopolitical exposure tied to its Israeli headquarters has also been cited as a risk factor, adding to investor caution.

Key Areas to Watch Going Forward

Looking ahead, investors are likely to monitor several factors that could shape ODYS's trajectory. Backlog conversion is a central metric; the company reported a backlog of approximately $13.8 million as of December 31, 2025, and the pace at which those orders translate into recognized revenue will be closely watched. Progress in diversifying its customer base beyond its historically concentrated top three customers is another key theme.

Cash runway and capital-raising activity remain important, given management's expectation of continued expense growth and the potential need for additional funding before reaching profitability. Macroeconomic and geopolitical developments affecting defense and industrial budgets, as well as any new partnerships or pilot-order announcements, could also influence sentiment. As always, these factors should be evaluated alongside each investor's own research and risk tolerance. I’m watching this closely as part of my ongoing review of small-cap names in the sector.

Using AI Tools in My Research Process

In my own analysis, I sometimes turn to Tickeron’s AI Trading Bots to test systematic approaches alongside fundamental review. These tools help evaluate strategies across different timeframes and market conditions, providing a data-driven layer that complements traditional research. The platform offers access to a range of bots, allowing users to align options with their preferred style without replacing independent judgment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ODYS

Contributor

Dem Sem's AvatarDem Sem|Expert

ODYS in +12.43% Uptrend, growing for three consecutive days on November 02, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ODYS advanced for three days, in 76 of 92 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for ODYS just turned positive on October 26, 2026. Looking at past instances where ODYS's MACD turned positive, the stock continued to rise in 33 of 43 cases over the following month. The odds of a continued upward trend are 77%.

ODYS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ODYS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for ODYS entered a downward trend on November 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.749) is normal, around the industry mean (1.448). P/E Ratio (-1.645) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (51.282) is also within normal values, averaging (32.028).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. ODYS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ODYS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.

Industry description

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

Market Cap

The average market capitalization across the Electronic Equipment/Instruments Industry is 7.99B. The market cap for tickers in the group ranges from 12.56K to 120.89B. KYCCF holds the highest valuation in this group at 120.89B. The lowest valued company is FLXT at 12.56K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Equipment/Instruments Industry was 3%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was -15%. AIMD experienced the highest price growth at 70%, while ARAI experienced the biggest fall at -52%.

Volume

The average weekly volume growth across all stocks in the Electronic Equipment/Instruments Industry was 68%. For the same stocks of the Industry, the average monthly volume growth was 305% and the average quarterly volume growth was 117%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 51
Price Growth Rating: 63
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: 7 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ElectronicEquipmentInstruments

Industry
N/A
Address
12 Abba Hillel Silver Road
Phone
+972 733704690
Employees
52
Web
https://www.odysight.ai
Interact to see
Advertisement
AMD fell -5.03% to $555.85 in regular-session trading Friday, down -$29.45 from Thursday's close of $585.30, as of 9:42 a.m. ET shortly after the opening bell. No verified company-specific news or fundamental catalyst found: the decline tracks a broad semiconductor pullback and is consistent with profit-taking after a +44.7% rebound from the Nov. 5 close of $404.40, with the stock's typical daily swing running at 3.6%.
BZ dropped sharply, sliding from a $16.72 prior close to $13.48 (-19.38%), with the decline beginning in premarket and deepening into the early regular session. No verified company-specific news or fundamental catalyst was issued; the fall tracked a broad China ADR selloff (the Nasdaq Golden Dragon index slid more than 2%), but that alone is too small to explain a ~20% drop — the stock's Hong Kong listing fell only -2.6%.
NBIS fell from $154.69 to $129.12, down -16.53%, with the decline starting in premarket trading and continuing through the regular session. The drop followed Q3 results: revenue of $980.8M (+571% YoY) beat estimates, but management cut 2026 revenue guidance to the low end of its range on third-party capacity delays and raised 2026 capex to roughly $27B, reviving financing and execution fears.
The $1 target in this article is not an analyst price target; it is the $1.00 Nasdaq minimum bid price requirement, the level Cenntro itself has publicly targeted through a 1-for-60 reverse stock split. Cenntro trades near $0.12 per share, meaning reaching $1 would require an increase of roughly 730%—an exceptionally large move.
The central target of $21 is the arithmetic mean of three recently attributable analyst price targets on RUM — $25 (Lake Street), $15 (Texas Capital), and $22 (Maxim Group) — which average roughly $20.67. With shares trading near $5.90 after a post-earnings surge, reaching $21 would require a gain of roughly 256%, a very large move.